One-year results of excimer laser in situ keratomileusis for hyperopia

Abstract

Purpose: To evaluate the visual and refractive results of hyperopic LASIK. Setting: Clínica Baviera Instituto Oftalmológico Europeo, Madrid, Spain. Methods: This retrospective consecutive noncomparative observational study evaluated hyperopic LASIK results over 1 year. Outcomes included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), cycloplegic refraction, and corneal topography. Surgery was performed using an MEL 80-G excimer laser. Results were analyzed by preoperative spherical equivalent (SE) (Group 1: ≤+3.50 diopters [D]; Group 2: ≥+3.60 D). Results: The mean UDVA improved from 0.50 ± 0.3 (SD) to 0.90 ± 0.2 in Group 1 and from 0.50 ± 0.3 to 0.80 ± 0.2 in Group 2 and the mean CDVA, from 0.86 ± 0.2 to 0.93 ± 0.1 and from 0.80 ± 0.2 to 0.90 ± 0.2, respectively. The mean cycloplegic SE improved from +2. 5± 0.8 to +0.1 ± 0.5 in Group 1 and from +4.5 ± 0.6 to +0.4 ± 0.6 in Group 2; 70.9% of eyes and 63.3% of eyes, respectively, were within ±0.50 D of emmetropia. Postoperatively, 92.8% of eyes in Group 1 and 87.8% in Group 2 maintained or gained 1 or more lines of CDVA; 1.7% and 4.0%, respectively, lost 2 or more lines. The safety index was 1.1 in both groups and the efficacy index, 1.01 in Group 1 and 0.98 in Group 2. The enhancement rate was 20.0% and 18.4%, respectively. Conclusion: Excimer laser LASIK was safe and effective for treating hyperopia up to +6.25 D with no further loss of CDVA lines after enhancement. © 2009 ASCRS and ESCRS.